Clinical trial
Prophylactic Pulmonary Vein Isolation During Atrial Flutter Ablation: The PREVENT-AF Study II
NCT07649603 is registered in ClinicalTrials.gov with University of Rochester as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prophylactic Pulmonary Vein Isolation During Atrial Flutter Ablation: The PREVENT-AF Study II
- Lead sponsor
- University of Rochester
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- June 30, 2027
- Completion date
- May 31, 2032
- Enrollment
- 620 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
atrial flutter typical